• Why Abercrombie & Fitch, Triumph Group, and Puma Biotechnology Jumped Today - Motley Fool

    Why Abercrombie & Fitch, Triumph Group, and Puma Biotechnology Jumped Today - Motley Fool
    Motley Fool
    Why Abercrombie & Fitch, Triumph Group, and Puma Biotechnology Jumped Today
    Motley Fool
    On a strong day for the market, these stocks led the way higher. Find out why. Dan Caplinger. (TMFGalagan). May 24, 2017 at 4:17PM. Wednesday was a good day for stocks, and the Dow Jones Industrials and S&P 500 both climbed through milestone levels.
    Cerberus, American Eagle Work on Joint Bid for Abercrombie & FitchWall Street Journalall 106 news articles »
  • Amicus Therapeutics: A Rare Find In Biotechnology - Seeking Alpha

    Amicus Therapeutics: A Rare Find In Biotechnology
    Seeking Alpha
    Amicus Therapeutics has advanced the first Fabry disease medicine, Galafold, through EMA and is working to obtain FDA approval in further studies. The company is developing ATB/AT2221 in Pompe's Disease, with key data readouts in 2017. Amicus is also ...
  • BRIEF-Puma Biotechnology receives FDA advisory committee support for Neratinib - Reuters

    BRIEF-Puma Biotechnology receives FDA advisory committee support for Neratinib
    Reuters
    BERLIN, May 25 Former U.S. President Barack Obama told an audience in Berlin on Thursday that prosperous nations could not "hide behind a wall" to shield themelves from the turmoil and poverty afflicting other countries.
  • BIO 2017 Innovation Zone Company Snapshot: Xeris Pharmaceuticals, Inc.

    BIO 2017 Innovation Zone Company Snapshot: Xeris Pharmaceuticals, Inc.
    The next big medical breakthrough may start in a small business with a big idea. Recognizing the potential and promise of early-stage companies for addressing unmet medical needs, the BIO International Convention will once again host the Innovation Zone on the exhibit floor of the San Diego Convention Center, June 19-22. Eighty emerging companies will showcase biotechnology breakthroughs in drug discovery, diagnostics, and other therapeutic platform technologies.
    The Innovation Zone was created
  • Advertisement

  • BBP: A Diversified Biotech ETF - Seeking Alpha

    BBP: A Diversified Biotech ETF - Seeking Alpha
    Seeking Alpha
    BBP: A Diversified Biotech ETF
    Seeking Alpha
    The BioShares Biotechnology Products ETF equal weights those biotechs that have an FDA-approved product. The equal weighting strategy produces a portfolio that is better diversified than IBB, which is dominated by the biotech mega caps. The fund's ...
  • Canning association offers R&D to biotechnology companies - FIS

    Canning association offers R&D to biotechnology companies
    FIS
    The canning association ANFACO-CECOPESCA offered the biotechnology sector of Galicia its R&D in blue biotechnology to advance in the creation of new functional compounds. Thirty companies from the Business Technology Cluster of Life Sciences ...and more »
  • Puma Biotechnology FDA Live Blog - Forbes

    Puma Biotechnology FDA Live Blog - Forbes
    Forbes
    Puma Biotechnology FDA Live Blog
    Forbes
    This is a live blog of the meeting of the Food and Drug Administration's meeting regarding neratinib, a breast cancer drug being developed by Puma Biotechnology. The basic questions to be addressed, per my story from Monday. Puma's not applying to sell ...
    Why Puma Biotechnology Inc Jumped Higher TodayMotley Fool
    Puma Biotechnology (PBYI) Jumps: Stock Adds 29.7% in SessionZacks.com
    Puma Pulls Within Sight Of FDA OKSeeking Alpha
    Business Wire (

Follow @Biotech_News_ on Twitter!